CirrhosisRx CDS System
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco
About this trial
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
Eligibility criteria
Qualifiers
All adult (age ≥ 18 years) patients who have cirrhosis identified based on 1+ chronic liver disease and 1+ cirrhosis (or its complications) International Classification of Diseases, Revision 10 diagnosis codes OR mention of cirrhosis or portal hypertension (or their complications) in clinical documentation admitted at our institution.
Disqualifiers
Children (age < 18 years)
patients who do not meet the cirrhosis definition criteria as noted above
ambulatory patients
Trial design
Treatments tested in this trial
- CirrhosisRx CDS
Treatment groups
2,106 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov